SCHEMBL3244429

SCHEMBL3244429

Cc1ccccc1S(=O)(=O)N(CC(N)=O)c1ccc(Cl)cc1Cc1ccccc1Cl

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PTGER1 P34995 3/20 0.42
FDFT1 P37268 1/20 0.39
THRB P10828 3/20 0.39
ALDH1A1 P00352 2/20 0.39
POLB P06746 2/20 0.39
LMNA P02545 1/20 0.39
KCNJ6 P48051 1/20 0.39
KCNJ5 P48544 1/20 0.39
KCNJ3 P48549 1/20 0.39
KEAP1 Q14145 4/20 0.38
NFE2L2 Q16236 4/20 0.38
HCRTR2 O43614 2/20 0.38
TP53 P04637 1/20 0.36
MAPT P10636 1/20 0.36
MEN1 O00255 1/20 0.36
GAA P10253 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3256139 0.92 PTGER1 (0.44) PTGER1FDFT1THRBALDH1A1POLB
SCHEMBL3250637 0.91 FDFT1 (0.39) PTGER1FDFT1THRBALDH1A1POLB
SCHEMBL4868968 0.90 FDFT1 (0.38) PTGER1FDFT1THRBALDH1A1POLB
SCHEMBL3249343 0.90 PTGER1 (0.39) PTGER1FDFT1THRBALDH1A1POLB
SCHEMBL13357732 0.88 KEAP1 (0.39) PTGER1FDFT1THRBALDH1A1POLB
SCHEMBL3251134 0.87 PTGER1 (0.47) PTGER1FDFT1ALDH1A1POLBLMNA
SCHEMBL4860804 0.86 KEAP1 (0.43) PTGER1THRBALDH1A1KEAP1NFE2L2
SCHEMBL3266443 0.86 PTGER1 (0.43) PTGER1FDFT1ALDH1A1LMNAKEAP1
SCHEMBL3251187 0.86 THRB (0.44) PTGER1FDFT1THRBKEAP1NFE2L2
SCHEMBL4869119 0.85 KEAP1 (0.38) PTGER1FDFT1THRBPOLBKCNJ5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1776347-B1 SULPHONAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI AVENTIS (FR) 2010-05-26 EP disclosed
US-7396958-B2 Sulphonamide derivatives, their preparation and their therapeutic application SANOFI AVENTIS (FR) 2008-07-08 US disclosed
US-7396958-B2 Sulphonamide derivatives, their preparation and their therapeutic application SANOFI AVENTIS (FR) 2008-07-08 US disclosed
US-7396958-B2 Sulphonamide derivatives, their preparation and their therapeutic application SANOFI AVENTIS (FR) 2008-07-08 US disclosed
US-20070185136-A1 SULPHONAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI-AVENTIS (FR) 2007-08-09 US disclosed
US-20070185136-A1 SULPHONAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI-AVENTIS (FR) 2007-08-09 US disclosed
US-20070185136-A1 SULPHONAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI-AVENTIS (FR) 2007-08-09 US disclosed
WO-2006024779-A1 SULPHONAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI-AVENTIS (FR) 2006-03-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070185136-A1 SULPHONAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION HCRTR2, GIPR, SSTR2 PTGER1 4534/4885FDFT1 1608/4885THRB 84/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.